457 related articles for article (PubMed ID: 11419839)
1. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
[TBL] [Abstract][Full Text] [Related]
3. Local ablation procedures in primary liver tumors: Levovist US versus spiral CTto evaluate therapeutic results.
Vallone P; Gallipoli A; Izzo F; Fiore F; Delrio P
Anticancer Res; 2003; 23(6D):5075-9. PubMed ID: 14981969
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization.
Angeli E; Carpanelli R; Crespi G; Zanello A; Sironi S; Del Maschio A
Radiol Med; 1994 May; 87(5 Suppl 1):24-31. PubMed ID: 8209014
[TBL] [Abstract][Full Text] [Related]
5. Levovist-enhanced Doppler sonography versus spiral computed tomography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma.
Fiore F; Vallone P; Ricchi P; Tambaro R; Daniele B; Sandomenico F; De Vivo R; Civiletti C; Izzo F; Pignata S; Ziviello M
J Clin Gastroenterol; 2000 Sep; 31(2):164-8. PubMed ID: 10993437
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
[TBL] [Abstract][Full Text] [Related]
7. Enhanced color flows in hepatic tumors.
Yang CC; Chen CH; Yeh YH
Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
[TBL] [Abstract][Full Text] [Related]
9. [Vascularization patterns in focal liver lesions: comparison of plain and signal-enhanced amplitude-modulated color duplex ultrasonography].
Hosten N; Steger W; Bechstein WO; Zendel WJ; Venz S; Lemke AJ; Weber S; Vogl TJ; Felix R
Rofo; 1997 Jun; 166(6):507-13. PubMed ID: 9273003
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
[TBL] [Abstract][Full Text] [Related]
11. Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy.
Koito K; Namieno T; Ichimura T; Hirokawa N; Syonai T; Hareyama M; Katsuramaki T; Hirata K; Nishi M
AJR Am J Roentgenol; 2000 Feb; 174(2):337-41. PubMed ID: 10658701
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
[TBL] [Abstract][Full Text] [Related]
13. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
15. [The correlation between Doppler echography with a contrast medium and CT in the study of a hepatocarcinoma submitted to chemoembolization].
Catalano O; Cusati B; Esposito M; Trivellini V; Lobianco R; Siani A
Radiol Med; 1998 Jun; 95(6):608-13. PubMed ID: 9717543
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US.
Bartolozzi C; Lencioni R; Ricci P; Paolicchi A; Rossi P; Passariello R
Radiology; 1998 Nov; 209(2):387-93. PubMed ID: 9807563
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
[TBL] [Abstract][Full Text] [Related]
18. Power Doppler sonography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma.
Spiezia S; Vallone P; Fiore F; Ricchi P; Daniele B; Picone G; Cerbone G; De Vivo R; Perrone F; Castiglione F; Pignata S
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):548-53. PubMed ID: 9513831
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound.
Cioni D; Lencioni R; Bartolozzi C
Eur Radiol; 2000; 10(10):1570-5. PubMed ID: 11044926
[TBL] [Abstract][Full Text] [Related]
20. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
